Joel D. Rosen, Esq, managing partner of High Swartz LLP, has been elected Chair of the Baruch S. Blumberg Institute’s Board of Directors.
Located in Doylestown, the Blumberg Institute is a nonprofit organization established by the Hepatitis B Foundation. The Institute’s research includes developing therapeutics for the treatment and cure of chronic hepatitis B.
Mr. Rosen served on the Hepatitis B Foundation’s Board of Directors for nearly two decades, including 13 years as Chair.
Mr. Rosen is a Corporate Law Attorney at High Swartz LLP, practicing franchise law, business, commercial law, employment law, trademark/copyright law and commercial leasing. His corporate client base covers a broad range of industries, including biotechnology.
About the Baruch S. Blumberg Institute: An independent, nonprofit research organization, the Blumberg Institute was launched in 2003 by the Hepatitis B Foundation to advance its research mission. Today, the Institute is a leading center for translational research in hepatitis B and liver cancer. The Institute supports drug discovery, biomarker discovery and translational biotechnology around common research themes such as chronic hepatitis, liver disease and liver cancer in an environment conducive to interaction, collaboration and focus. The Blumberg Institute is located in the Pennsylvania Biotechnology Center, which it manages, near Doylestown, Pa. Visit www.blumberginstitute.org and follow us on Twitter @BlumbergInstit1.
Joel D. Rosen, Esq, managing partner of High Swartz LLP, has been elected Chair of the Baruch S. Blumberg Institute’s Board of Directors.
Located in Doylestown, the Blumberg Institute is a nonprofit organization established by the Hepatitis B Foundation. The Institute’s research includes developing therapeutics for the treatment and cure of chronic hepatitis B.
Mr. Rosen served on the Hepatitis B Foundation’s Board of Directors for nearly two decades, including 13 years as Chair.
Mr. Rosen is a Corporate Law Attorney at High Swartz LLP, practicing franchise law, business, commercial law, employment law, trademark/copyright law and commercial leasing. His corporate client base covers a broad range of industries, including biotechnology.
About the Baruch S. Blumberg Institute: An independent, nonprofit research organization, the Blumberg Institute was launched in 2003 by the Hepatitis B Foundation to advance its research mission. Today, the Institute is a leading center for translational research in hepatitis B and liver cancer. The Institute supports drug discovery, biomarker discovery and translational biotechnology around common research themes such as chronic hepatitis, liver disease and liver cancer in an environment conducive to interaction, collaboration and focus. The Blumberg Institute is located in the Pennsylvania Biotechnology Center, which it manages, near Doylestown, Pa. Visit www.blumberginstitute.org and follow us on Twitter @BlumbergInstit1.